Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,789 papers from all fields of science
Search
Sign In
Create Free Account
ZD 0473
Known as:
ZD-0473
, ZD0473
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Picoplatin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
New Developments and Approaches in the Platinum Arena
I. Judson
,
L. Kelland
Drugs
2012
Corpus ID: 25305006
Following the introduction of cisplatin and the demonstration of its importance in the treatment of testicular and ovarian cancer…
Expand
2003
2003
A comparison of the quantitative methods for the analysis of the platinum-containing anticancer drug [cis-[amminedichloro(2-methylpyridine)]platinum(II)] (ZD0473) by HPLC coupled to either a triple…
Christopher J. Smith
,
I. Wilson
,
+4 authors
D. Roberts
Analytical Chemistry
2003
Corpus ID: 29949884
The use of high performance liquid chromatography coupled with inductively coupled plasma mass spectrometry (HPLC-ICPMS) as means…
Expand
2003
2003
In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line.
F. Kanzawa
,
Y. Akiyama
,
N. Saijo
,
K. Nishio
Lung Cancer
2003
Corpus ID: 9044101
2003
2003
Determination of the platinum drug cis-amminedichloro(2-methylpyridine)platinum(II) in human urine by liquid chromatography-tandem mass spectrometry.
T. Oe
,
Ye Tian
,
P. O'dwyer
,
D. Roberts
,
Christopher J Bailey
,
I. Blair
Journal of chromatography. B, Analytical…
2003
Corpus ID: 13255175
2003
2003
AMD473 (ZD0473) exhibits marked in vitro anticancer activity in human tumor specimens taken directly from patients
L. Medina-Gundrum
,
Cesario Z. Cerna
,
L. Gomez
,
M. Yochmowitz
,
S. Weitman
Anti-Cancer Drugs
2003
Corpus ID: 24484913
AMD473 (ZD0473; cis-amminedichloro[2-methylpyridine]platinum [II]) is a new generation anticancer agent that, in preclinical…
Expand
Highly Cited
2002
Highly Cited
2002
Phase II trial of ZD0473 as second-line therapy in mesothelioma.
G. Giaccone
,
M. O'Brien
,
M. Byrne
,
M. Bard
,
E. Kaukel
,
B. Smit
European Journal of Cancer
2002
Corpus ID: 36680258
Review
2002
Review
2002
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval.
M. Gore
,
R. Atkinson
,
+6 authors
W. M. Smit
European Journal of Cancer
2002
Corpus ID: 24334604
Highly Cited
2000
Highly Cited
2000
Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.
J. Holford
,
Philip Beale
,
F. Boxall
,
S. Sharp
,
Lloyd R. Kelland
European Journal of Cancer
2000
Corpus ID: 22787685
Review
2000
Review
2000
Preclinical and clinical overview of the novel platinum complex, ZD0473 (cis-amminedichloro[2-methylpyridine] platinum[II])
L. Kelland
,
I. Judson
,
M. Koehler
,
T. Stevens
,
D. Roberts
2000
Corpus ID: 71314650
1999
1999
Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.
L. Kelland
Journal of Inorganic Biochemistry
1999
Corpus ID: 10916167
The platinum-based drugs, cisplatin and carboplatin, represent major agents in the chemotherapeutic treatment of a variety of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE